Related Experiment Video
Updated: Sep 8, 2025

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
A Comparison of Different Endovascular Treatment for Vertebral Artery Origin Stenosis
Zigao Wang1, Yifeng Ling1, Hongchen Zhao1
1Department of Neurology and Institute of Neurology, Huashan Hospital, Fudan University, Shanghai, China.
Insights
Drug-eluting stents (DES) are more effective than bare metal stents (BMS) for reducing restenosis in vertebral artery origin stenosis (VAOS). Angioplasty with drug-coated balloons (DCB) showed slower stenosis progression despite initial residual stenosis.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Vascular Surgery
Background:
- Vertebral artery origin stenosis (VAOS) can cause significant neurological symptoms.
- Medical management alone is often insufficient for symptomatic VAOS.
- Endovascular options are crucial for managing refractory VAOS.
Purpose of the Study:
- To compare the safety and efficacy of drug-eluting stent (DES) versus bare metal stent (BMS) and angioplasty with drug-coated balloon (DCB) for symptomatic VAOS.
- To evaluate outcomes including technical success, complications, residual stenosis, and long-term event rates.
- To identify the optimal endovascular strategy for patients unresponsive to medical therapy.
Main Methods:
- Retrospective analysis of 46 patients with symptomatic VAOS treated between December 2018 and November 2021.
- Comparison of three treatment groups: DES (n=29), BMS (n=12), and DCB angioplasty (n=5).
- Assessment of technical success, perioperative complications, residual stenosis, stroke recurrence, stenosis progression, and restenosis rates.
Main Results:
- Technical success rates were 100% for DES, 100% for BMS, and 60% for DCB (P=0.008).
- Restenosis rates were significantly lower with DES (6.9%) compared to BMS (50.0%) (P=0.007).
- DCB group showed the slowest progression of residual stenosis (-8.0%) despite higher initial residual stenosis (51.2%).
Conclusions:
- Drug-eluting stents (DES) demonstrate superior efficacy in reducing restenosis rates compared to bare metal stents (BMS) in VAOS.
- Angioplasty with drug-coated balloons (DCB) offers a viable alternative, characterized by slower stenosis progression.
- Endovascular treatment strategies should be individualized based on patient factors and desired outcomes for symptomatic VAOS.
Objective:
To compare the safety and efficacy of stenting with drug-eluting stent (DES), stenting with bare mental stent (BMS), and angioplasty alone with drug-coated balloon (DCB) in patients with symptomatic vertebral artery origin stenosis (VAOS) who did not respond to aggressive medical management.
Methods:
We performed a retrospective analysis of consecutive patients with symptomatic VAOS who underwent endovascular treatment between December 2018 and November 2021 at our institution. The main outcome compared were technical success, perioperative complications, residual stenosis, stroke recurrence, progression of residual stenosis, and restenosis.
Results:
A total of 46 patients were included: 29 were stented with DES, 12 were stented with BMS, and 5 received angioplasty alone with DCB. Technical success was achieved in 100%, 100%, and 60%, respectively (P = 0.008). Residual stenosis was 10.8%, 20.2%, and 51.2%, respectively (P < 0.001). Perioperative complications occurred only in 1 case in the DES group (P = 1.00). During a mean follow-up of 14.1 months, stroke recurrence rate was 6.9%, 16.7%, and 0% respectively (P = 0.73). Absolute progression of residual stenosis was 10.1%, 34.9%, and -8.0%, respectively (P < 0.001). Restenosis rate was 6.9%, 50.0%, and 20.0%, respectively (P = 0.007).
Conclusions:
In patients with symptomatic VAOS who did not respond to aggressive medical management, stenting with DES shows superiority in the lowering the restenosis rate compared with stenting with BMS. Angioplasty alone with DCB is associated with the slowest progression of stenosis in spite of moderate residual stenosis.
More Related Videos
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
14:58Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
Published on: October 20, 2017
Related Concept Videos
Aneurysm III: Interprofessional Care
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care